Christopher Schelling
Directeur/Bestuurslid bij Cascade Prodrug, Inc.
Oorsprong van het eerstegraads netwerk van Christopher Schelling
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
| Subsidiary | Pharmaceuticals: Major | 26 | |
Cascade Prodrug, Inc.
 Cascade Prodrug, Inc. Pharmaceuticals: MajorHealth Technology Cascade Prodrug, Inc. engages is the research and development of targeted prodrug therapies. It provides technology for the treatment of hyper-proliferative diseases. The company was founded by August J. Sick and Allan Cochrane and is headquartered in Eugene, OR.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Censa Pharmaceuticals, Inc.
 Censa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher Schelling via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Treasurer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| HUMANIGEN, INC. | Biotechnology | Director of Finance/CFO General Counsel Director/Board Member | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Human Resources Officer | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
| ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Boston College | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Masters Business Admin | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Corporate Officer/Principal | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Florida Institute of Certified Public Accountants | Corporate Officer/Principal | ||
| The Royal College of Physicians | College/University | Corporate Officer/Principal Graduate Degree | |
Simon-Kucher & Partners GmbH
 Simon-Kucher & Partners GmbH Miscellaneous Commercial ServicesCommercial Services Simon-Kucher & Partners GmbH provides strategy, marketing and pricing services. It offers consulting services in the areas of setting and managing prices, strategic development, product and market strategy, marketing leadership, and sales execution. The firm has offices in Amsterdam, Bonn, Boston, Brussels, Cologne, Frankfurt, London, Luxembourg, Barcelona, Madrid, Milan, Moscow, Munich, New York, Paris, San Francisco, Tokyo, Vienna, Warsaw, Beijing, Singapore, Sydney and Zurich. The company was founded by Hermann Simon, Eckhard Kucher and Karl-Heinz Sebastian in 1985 and is headquartered in Bonn, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Atacama Therapeutics, Inc.
 Atacama Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Atacama Therapeutics, Inc. is a company that focuses on developing treatments for acne vulgaris. The company is based in Wellesley, MA. The company has a pipeline product called AT-5214. The company was founded by Jefferson E. Davis, Jonathan Reis, Joseph Baron. Joseph Baron has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
| National Pku Alliance | Director/Board Member Director/Board Member | ||
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Harvard Kennedy School of Government | College/University | Graduate Degree | |
| The University of Cincinnati College of Medicine | College/University | Doctorate Degree | |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Verenigd Koninkrijk | 3 |
| Duitsland | 2 |
| Australië | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Consumer Durables | 2 |
Operationeel
| Director/Board Member | 220 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 66 |
| Chief Tech/Sci/R&D Officer | 48 |
| Undergraduate Degree | 42 |
Sterkste connecties
| Insiders | |
|---|---|
| William Young | 32 |
| Luc Marengère | 31 |
| Hubert Birner | 27 |
| Leonard Post | 25 |
| Dan Spiegelman | 25 |
| Joseph Klein | 24 |
| V. Lawlis | 21 |
| Stephen Aselage | 20 |
| Ken Bate | 19 |
| Randy Meier | 18 |
| Michelle Griffin | 18 |
| John Dunn | 15 |
| Bill Aliski | 13 |
| Jason Amello | 11 |
| Suyash Prasad | 11 |
- Beurs
- Insiders
- Christopher Schelling
- Bedrijfsconnecties
